X-Message-Number: 29875
Date: Tue, 02 Oct 2007 20:03:12 -0700
From: Olaf Henny <>
Subject: New vaccine technology
References: <>

A new vaccine technology based on development of antibodies will 
shorten reaction time considerably over the present practice of 
using chicken eggs.  The resulting shortening of reaction time 
will make the so much anticipated flu pandemic much less likely 
to occur.  The vaccines derived from cell cultures are 
anticipated to be available already this winter in Europe.



Quote:  About the Novartis Vaccines influenza vaccines pipeline

Cell culture-derived influenza vaccines use modern biotechnology 
cell cultures rather than chicken eggs for primary production. 
Current egg-based influenza vaccines production requires several 
months of logistics for ordering and receiving eggs. This lead 
time can hinder the response to unanticipated demands such as the 
discovery of pandemic strains, production failures and seasonal 
influenza virus strain changes. In contrast, flu cell culture 
production enables flexible, faster start-up of vaccine 
manufacturing, and does not depend upon the availability of eggs, 
providing a particularly important advantage in the event of an 
influenza pandemic. Unquote

For complete article see: 
http://novartisvaccines.com/press-room/news/20060718-HollySpringsPlant.shtml

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=29875